FindMyKOL
Clinical trialNCT03403413TerminatedInterventional

Muscle Vibration in MS to Improve Walking

NCT03403413 is an interventional trial sponsored by VA Office of Research and Development. As of 21 Nov 2026, it was terminated. It studies Multiple Sclerosis. The registry lists an enrollment of 5 participants at 1 site in 1 country. The registry lists a start date of 1 Jan 2017 and a primary completion date of 31 Dec 2018.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03403413
FieldValue
Registry IDNCT03403413
StatusTerminated
Study typeInterventional trial
Lead sponsorVA Office of Research and Development
Enrollment5
Registered sites1
Countries1
ConditionsMultiple Sclerosis
Start1 Jan 2017
Primary completion31 Dec 2018
Study completion31 Dec 2018
Last update posted8 May 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary goal of this pilot study is to explore the feasibility of cyclic vibration (CV) of the lower extremity muscles to improve walking in individuals with gait deficits from multiple sclerosis (MS).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Stephen M. Selkirk, MD PhD

    Louis Stokes VA Medical Center, Cleveland, OH

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • Louis Stokes Va Medical Center, Cleveland, Oh

    Cleveland

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03403413

Each answer restates registry values shown on this page.

What is NCT03403413?

NCT03403413 is an interventional trial sponsored by VA Office of Research and Development. It studies Multiple Sclerosis.

Who leads NCT03403413?

The registry names Stephen M. Selkirk, MD PhD (principal investigator, Louis Stokes VA Medical Center, Cleveland, OH) as the overall official.

Where does NCT03403413 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT03403413 end?

The registry lists a primary completion date of 31 Dec 2018 and a study completion date of 31 Dec 2018. The sponsor last updated the record on 8 May 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.